-
Je něco špatně v tomto záznamu ?
Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats
L. Kleteckova, G. Tsenov, H. Kubova, A. Stuchlik, K. Vales,
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- glutamáty terapeutické užití toxicita MeSH
- hipokampus účinky léků patologie MeSH
- ischemie mozku farmakoterapie MeSH
- krysa rodu rattus MeSH
- modely nemocí na zvířatech MeSH
- neuroprotektivní látky terapeutické užití MeSH
- potkani Wistar MeSH
- pregnanolon analogy a deriváty terapeutické užití toxicita MeSH
- receptory N-methyl-D-aspartátu antagonisté a inhibitory MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The perinatal hypoxic-ischemic insult frequently leads to mortality, morbidity and plays a key role in the later pathological consequences. The ischemic insult causes a massive release of glutamate and subsequent excitotoxic damage. The neuroactive steroid 3α5β-pregnanolone glutamate (PG) is a NMDA receptor antagonist acting via use-dependent mechanism and can be used as a neuroprotective agent that may alleviate glutamatergic excitotoxicity in the brain. First, a possible neurotoxic effect of the PG, a novel use-dependent NMDA antagonist, was studied in immature rats. In addition, to compare this effect with a well-described non-competitive NMDA antagonist, the MK-801 (positive control) was used. Animals at postnatal day 12 (P12) were injected intraperitoneally with PG in a doses 1 or 10mg/kg or with MK-801 in a dose 1mg/kg. Effect of PG treatment on the immature brain was evaluated on Fluoro Jade B (FJB) stained sections. Second, a neuroprotective effect of the PG was studied in the model of focal cerebral ischemia in P12. Focal cerebral ischemia was induced by the infusion of the endothelin-1 (ET-1) into the right dorsal hippocampus. PG at the doses 1 or 10mg/kg was administrated intraperitoneally 5min after the end of ET-1 infusion. To evaluate the neuroprotective effect after the PG treatment FJB staining was used. Our results demonstrate a lack of the neurotoxicity of the PG in intact P12. In the second part of the study in the model of the focal ischemia we detected significantly lower occurrence of FJB-positive cells in the afflicted hippocampus in PG treated groups, while animals without PG treatment exhibited massive neurodegeneration. The neuroprotective potential of the PG can serve in the development of therapeutic strategies for brain damage induced by the glutamate excitotoxicity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008324
- 003
- CZ-PrNML
- 005
- 20150331110513.0
- 007
- ta
- 008
- 150306s2014 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neulet.2014.01.057 $2 doi
- 035 __
- $a (PubMed)24513236
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Kleteckova, Lenka $u Department of Neurophysiology of Memory, Institute of Physiology, v.v.i. Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic; 2nd Faculty of Medicine, Charles University, Prague, Czech Republic, V Uvalu 84, 150 06 Prague 5-Motol, Czech Republic.
- 245 10
- $a Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats / $c L. Kleteckova, G. Tsenov, H. Kubova, A. Stuchlik, K. Vales,
- 520 9_
- $a The perinatal hypoxic-ischemic insult frequently leads to mortality, morbidity and plays a key role in the later pathological consequences. The ischemic insult causes a massive release of glutamate and subsequent excitotoxic damage. The neuroactive steroid 3α5β-pregnanolone glutamate (PG) is a NMDA receptor antagonist acting via use-dependent mechanism and can be used as a neuroprotective agent that may alleviate glutamatergic excitotoxicity in the brain. First, a possible neurotoxic effect of the PG, a novel use-dependent NMDA antagonist, was studied in immature rats. In addition, to compare this effect with a well-described non-competitive NMDA antagonist, the MK-801 (positive control) was used. Animals at postnatal day 12 (P12) were injected intraperitoneally with PG in a doses 1 or 10mg/kg or with MK-801 in a dose 1mg/kg. Effect of PG treatment on the immature brain was evaluated on Fluoro Jade B (FJB) stained sections. Second, a neuroprotective effect of the PG was studied in the model of focal cerebral ischemia in P12. Focal cerebral ischemia was induced by the infusion of the endothelin-1 (ET-1) into the right dorsal hippocampus. PG at the doses 1 or 10mg/kg was administrated intraperitoneally 5min after the end of ET-1 infusion. To evaluate the neuroprotective effect after the PG treatment FJB staining was used. Our results demonstrate a lack of the neurotoxicity of the PG in intact P12. In the second part of the study in the model of the focal ischemia we detected significantly lower occurrence of FJB-positive cells in the afflicted hippocampus in PG treated groups, while animals without PG treatment exhibited massive neurodegeneration. The neuroprotective potential of the PG can serve in the development of therapeutic strategies for brain damage induced by the glutamate excitotoxicity.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ischemie mozku $x farmakoterapie $7 D002545
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a glutamáty $x terapeutické užití $x toxicita $7 D005971
- 650 _2
- $a hipokampus $x účinky léků $x patologie $7 D006624
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a neuroprotektivní látky $x terapeutické užití $7 D018696
- 650 _2
- $a pregnanolon $x analogy a deriváty $x terapeutické užití $x toxicita $7 D011280
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory N-methyl-D-aspartátu $x antagonisté a inhibitory $7 D016194
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tsenov, Grygoriy $u Department of Developmental Epileptology, Institute of Physiology, v.v.i. Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic.
- 700 1_
- $a Kubova, Hana $u Department of Developmental Epileptology, Institute of Physiology, v.v.i. Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic.
- 700 1_
- $a Stuchlik, Ales $u Department of Neurophysiology of Memory, Institute of Physiology, v.v.i. Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic.
- 700 1_
- $a Vales, Karel $u Department of Neurophysiology of Memory, Institute of Physiology, v.v.i. Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic. Electronic address: vales@biomed.cas.cz.
- 773 0_
- $w MED00003507 $t Neuroscience letters $x 1872-7972 $g Roč. 564, č. - (2014), s. 11-5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24513236 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150331110742 $b ABA008
- 999 __
- $a ok $b bmc $g 1065597 $s 891124
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 564 $c - $d 11-5 $i 1872-7972 $m Neuroscience letters $n Neurosci. lett. $x MED00003507
- LZP __
- $a Pubmed-20150306
